Regulation of contractility and metabolic signaling by the β2-adrenergic receptor in rat ventricular muscle

Joaquín Pérez-Schindler, Andrew Philp, Keith Baar, Jesús Hernández-Cascales

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Aims: Cardiac function is modulated by the sympathetic nervous system through β-adrenergic receptor (β-AR) activity and this represents the main regulatory mechanism for cardiac performance. To date, however, the metabolic and molecular responses to β2-agonists are not well characterized. Therefore, we studied the inotropic effect and signaling response to selective β2-AR activation by tulobuterol. Main methods: Strips of rat right ventricle were electrically stimulated (1 Hz) in standard Tyrode solution (95% O2, 5% CO2) in the presence of the β1-antagonist CGP-20712A (1 μM). A cumulative dose-response curve for tulobuterol (0.1-10 μM), in the presence or absence of the phosphodiesterase (PDE) inhibitor IBMX (30 μM), or 10 min incubation (1 μM) with the β2-agonist tulobuterol was performed. Key findings: β2-AR stimulation induced a positive inotropic effect (maximal effect = 33 ± 3.3%) and a decrease in the time required for half relaxation (from 45 ± 0.6 to 31 ± 1.8 ms, - 30%, p < 0.001) after the inhibition of PDEs. After 10 min of β2-AR stimulation, p-AMPKαT172 (54%), p-PKBT308 (38%), p-AS160 T642 (46%) and p-CREBS133 (63%) increased, without any change in p-PKAT197. Significance: These results suggest that the regulation of ventricular contractility is not the primary function of the β2-AR. Rather, β2-AR could function to activate PKB and AMPK signaling, thereby modulating muscle mass and energetic metabolism of rat ventricular muscle.

Original languageEnglish (US)
Pages (from-to)892-897
Number of pages6
JournalLife Sciences
Volume88
Issue number19-20
DOIs
StatePublished - May 9 2011

Fingerprint

Adrenergic Receptors
Muscle
Rats
Muscles
1-Methyl-3-isobutylxanthine
AMP-Activated Protein Kinases
Phosphodiesterase Inhibitors
Sympathetic Nervous System
Neurology
Metabolism
Heart Ventricles
Chemical activation
tulobuterol
Tyrode's solution
CGP 20712A

Keywords

  • β-adrenergic receptor
  • AMPK
  • Cardiac contractility
  • Cardiac metabolism
  • PI3K

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Regulation of contractility and metabolic signaling by the β2-adrenergic receptor in rat ventricular muscle. / Pérez-Schindler, Joaquín; Philp, Andrew; Baar, Keith; Hernández-Cascales, Jesús.

In: Life Sciences, Vol. 88, No. 19-20, 09.05.2011, p. 892-897.

Research output: Contribution to journalArticle

Pérez-Schindler, J, Philp, A, Baar, K & Hernández-Cascales, J 2011, 'Regulation of contractility and metabolic signaling by the β2-adrenergic receptor in rat ventricular muscle', Life Sciences, vol. 88, no. 19-20, pp. 892-897. https://doi.org/10.1016/j.lfs.2011.03.020
Pérez-Schindler, Joaquín ; Philp, Andrew ; Baar, Keith ; Hernández-Cascales, Jesús. / Regulation of contractility and metabolic signaling by the β2-adrenergic receptor in rat ventricular muscle. In: Life Sciences. 2011 ; Vol. 88, No. 19-20. pp. 892-897.
@article{4395eb68100b4624a1d60a9b66b635df,
title = "Regulation of contractility and metabolic signaling by the β2-adrenergic receptor in rat ventricular muscle",
abstract = "Aims: Cardiac function is modulated by the sympathetic nervous system through β-adrenergic receptor (β-AR) activity and this represents the main regulatory mechanism for cardiac performance. To date, however, the metabolic and molecular responses to β2-agonists are not well characterized. Therefore, we studied the inotropic effect and signaling response to selective β2-AR activation by tulobuterol. Main methods: Strips of rat right ventricle were electrically stimulated (1 Hz) in standard Tyrode solution (95{\%} O2, 5{\%} CO2) in the presence of the β1-antagonist CGP-20712A (1 μM). A cumulative dose-response curve for tulobuterol (0.1-10 μM), in the presence or absence of the phosphodiesterase (PDE) inhibitor IBMX (30 μM), or 10 min incubation (1 μM) with the β2-agonist tulobuterol was performed. Key findings: β2-AR stimulation induced a positive inotropic effect (maximal effect = 33 ± 3.3{\%}) and a decrease in the time required for half relaxation (from 45 ± 0.6 to 31 ± 1.8 ms, - 30{\%}, p < 0.001) after the inhibition of PDEs. After 10 min of β2-AR stimulation, p-AMPKαT172 (54{\%}), p-PKBT308 (38{\%}), p-AS160 T642 (46{\%}) and p-CREBS133 (63{\%}) increased, without any change in p-PKAT197. Significance: These results suggest that the regulation of ventricular contractility is not the primary function of the β2-AR. Rather, β2-AR could function to activate PKB and AMPK signaling, thereby modulating muscle mass and energetic metabolism of rat ventricular muscle.",
keywords = "β-adrenergic receptor, AMPK, Cardiac contractility, Cardiac metabolism, PI3K",
author = "Joaqu{\'i}n P{\'e}rez-Schindler and Andrew Philp and Keith Baar and Jes{\'u}s Hern{\'a}ndez-Cascales",
year = "2011",
month = "5",
day = "9",
doi = "10.1016/j.lfs.2011.03.020",
language = "English (US)",
volume = "88",
pages = "892--897",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "19-20",

}

TY - JOUR

T1 - Regulation of contractility and metabolic signaling by the β2-adrenergic receptor in rat ventricular muscle

AU - Pérez-Schindler, Joaquín

AU - Philp, Andrew

AU - Baar, Keith

AU - Hernández-Cascales, Jesús

PY - 2011/5/9

Y1 - 2011/5/9

N2 - Aims: Cardiac function is modulated by the sympathetic nervous system through β-adrenergic receptor (β-AR) activity and this represents the main regulatory mechanism for cardiac performance. To date, however, the metabolic and molecular responses to β2-agonists are not well characterized. Therefore, we studied the inotropic effect and signaling response to selective β2-AR activation by tulobuterol. Main methods: Strips of rat right ventricle were electrically stimulated (1 Hz) in standard Tyrode solution (95% O2, 5% CO2) in the presence of the β1-antagonist CGP-20712A (1 μM). A cumulative dose-response curve for tulobuterol (0.1-10 μM), in the presence or absence of the phosphodiesterase (PDE) inhibitor IBMX (30 μM), or 10 min incubation (1 μM) with the β2-agonist tulobuterol was performed. Key findings: β2-AR stimulation induced a positive inotropic effect (maximal effect = 33 ± 3.3%) and a decrease in the time required for half relaxation (from 45 ± 0.6 to 31 ± 1.8 ms, - 30%, p < 0.001) after the inhibition of PDEs. After 10 min of β2-AR stimulation, p-AMPKαT172 (54%), p-PKBT308 (38%), p-AS160 T642 (46%) and p-CREBS133 (63%) increased, without any change in p-PKAT197. Significance: These results suggest that the regulation of ventricular contractility is not the primary function of the β2-AR. Rather, β2-AR could function to activate PKB and AMPK signaling, thereby modulating muscle mass and energetic metabolism of rat ventricular muscle.

AB - Aims: Cardiac function is modulated by the sympathetic nervous system through β-adrenergic receptor (β-AR) activity and this represents the main regulatory mechanism for cardiac performance. To date, however, the metabolic and molecular responses to β2-agonists are not well characterized. Therefore, we studied the inotropic effect and signaling response to selective β2-AR activation by tulobuterol. Main methods: Strips of rat right ventricle were electrically stimulated (1 Hz) in standard Tyrode solution (95% O2, 5% CO2) in the presence of the β1-antagonist CGP-20712A (1 μM). A cumulative dose-response curve for tulobuterol (0.1-10 μM), in the presence or absence of the phosphodiesterase (PDE) inhibitor IBMX (30 μM), or 10 min incubation (1 μM) with the β2-agonist tulobuterol was performed. Key findings: β2-AR stimulation induced a positive inotropic effect (maximal effect = 33 ± 3.3%) and a decrease in the time required for half relaxation (from 45 ± 0.6 to 31 ± 1.8 ms, - 30%, p < 0.001) after the inhibition of PDEs. After 10 min of β2-AR stimulation, p-AMPKαT172 (54%), p-PKBT308 (38%), p-AS160 T642 (46%) and p-CREBS133 (63%) increased, without any change in p-PKAT197. Significance: These results suggest that the regulation of ventricular contractility is not the primary function of the β2-AR. Rather, β2-AR could function to activate PKB and AMPK signaling, thereby modulating muscle mass and energetic metabolism of rat ventricular muscle.

KW - β-adrenergic receptor

KW - AMPK

KW - Cardiac contractility

KW - Cardiac metabolism

KW - PI3K

UR - http://www.scopus.com/inward/record.url?scp=79955508840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955508840&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2011.03.020

DO - 10.1016/j.lfs.2011.03.020

M3 - Article

C2 - 21466811

AN - SCOPUS:79955508840

VL - 88

SP - 892

EP - 897

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 19-20

ER -